Dr Reddys Laboratories Share Price Today - Live Blog for September 19, 2025

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.19% increase and currently trading at ₹1,323.60 per share. Investors are taking notice of this upward momentum.

With a -0.23% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,321.10. The stock is currently trading at a PE of 19.4300, while the industry PE is 35.2339, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd experienced a -0.28% dip in its share price and is currently trading at ₹1,321.35. The stock has a PE ratio of 19.4300, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,324.20. Notably, the stock's PE ratio stands at 19.4300, and its Return on Equity (ROE) is 16.8559%.

There were no changes in the share price of Dr Reddys Laboratories Ltd, which is currently at ₹1,322.00. During this period of price stability, investors may review the stock's financials and market positioning.

Following a noteworthy 0.04% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,322.55. When it comes to valuation, this stock has a PE ratio of 19.4300, with the industry PE ratio at 35.2339.

Dr Reddys Laboratories Ltd's stock price surged by 0.08%, reaching the current market value of ₹1,322.00 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd displayed no price movement, holding steady at ₹1,321.00. Interestingly, the stock maintains a Price-to-Earnings (PE) ratio of 19.4300, while the industry PE ratio stands at 35.2339, which might influence investors' decisions.

Dr Reddys Laboratories Ltd stock remained unchanged, maintaining its position at ₹1,321.00. During this period of price stability, investors can assess the stock's competitive advantages and market positioning.

Demonstrating a commendable 0.04% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,321.00. In terms of valuation, the stock maintains a PE ratio of 19.4300, while the industry PE ratio stands at 35.2339.

Dr Reddys Laboratories Ltd's share price stayed unchanged, currently trading at ₹1,320.00. The stock has a PE ratio of 19.4300, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd remained consistent, showing no variations, and is currently at ₹1,320.00. Investors may choose to delve into the stock's financial health and competitive positioning.

Dr Reddys Laboratories Ltd's share price stayed the same, currently trading at ₹1,320.00. The stock has a PE ratio of 19.4300, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% drop, and it's now trading at ₹1,320.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,320.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.15% boost, with the current market value at ₹1,321.50 per share. This surge has not gone unnoticed by investors.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,319.50. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.4300, while the industry PE is 35.2339.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.14% increase and currently trading at ₹1,320.00 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.19%, and as of now, it's trading at ₹1,318.10 per share. This upward trajectory is attracting keen interest from investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,315.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -0.14% decline, and it currently trades at ₹1,316.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd witnessed a notable 0.08% surge in its share price and is presently trading at ₹1,316.60, captivating the attention of market participants.

Dr Reddys Laboratories Ltd witnessed a -0.15% drop in its share price and is currently trading at ₹1,316.25. With the stock's PE at 19.4300 and the industry PE at 35.2339, investors are weighing their options.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.22%, reaching the current market price of ₹1,317.95. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.14% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,315.95. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.4300, while the industry PE is 35.2339.

Dr Reddys Laboratories Ltd experienced a -0.14% downturn in its share price, and it's currently trading at ₹1,318.20. This situation is generating interest among value investors who are evaluating the stock's potential.